Conference Coverage

Declining androgen levels correlated with increased frailty

Publish date: March 27, 2018

 

REPORTING FROM ENDO 2018

Dr. Wu is on the advisory board of Bayer-Schering, Eli Lilly, and Besins Healthcare. Dr. Wu is a research supporter or consultant for Repros Therapeutics, Merck Serono, and Mereo Biopharma. Investigators reported no additional relevant financial disclosures.

SOURCE: Wu F C et al. ENDO 2018, Abstract OR15-1.

Pages

Recommended Reading

Clinicians underusing statins, aspirin in HIV patients
MDedge Endocrinology
Testosterone Trials’ cardiac, cognitive results disappoint
MDedge Endocrinology
Ask patients about sexual function at first visit
MDedge Endocrinology
VIDEO: Low testosterone common after testicular cancer
MDedge Endocrinology
Hypogonadism after testicular cancer treatment can have lifelong impact
MDedge Endocrinology
Meta-analysis shows correlation between diabetes and erectile dysfunction
MDedge Endocrinology
Free testosterone linked to frailty in older men
MDedge Endocrinology
Without reliability, testosterone testing may fall short
MDedge Endocrinology
VIDEO: Researchers closing in on the elusive ‘male pill’
MDedge Endocrinology
MDedge Daily News: Stem cells may reverse premature menopause
MDedge Endocrinology